Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(9 sites)
United States
Mayo Clinic, Phoenix, Phoenix, Arizona Sarah Cannon Cancer Institute at HealthONE, Denver, Colorado Mayo Clinic, Jacksonville, Jacksonville, Florida Dana Farber Cancer Institute, Boston, Massachusetts START Midwest, Grand Rapids, Michigan Mayo Clinic, Rochester, Rochester, Minnesota Cleveland Clinic, Taussig Cancer Institute, Cleveland, Ohio NEXT Oncology, San Antonio, Texas NEXT Virginia, LLC, Fairfax, Virginia